Provision of Clinical Laboratory Services - Molecular Pathology Diagnostic Services (PD-L1 Testing Service)

CPV: Pathology services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

17 Jun 2026, 16:57 BST

Last source update

1 Jul 2026, 15:40 BST

FTS notice number

2026/S 000-061887

Classification (CPV)

Pathology services

Delivery area

North East (UKC)

Official registry OCID

ocds-h6vhtk-06b77f Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 30th June 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 30th June 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Award decision-makers: Nicola Sherriff - General Manager - Pathology Chrissie Parks - Care Group Accountant Based on the assessment and PSR decision making process (taking into account, key criteria: quality and innovation, value, integration, collaboration and service sustainability, improving access - reducing health inequalities and facilitating choice, social value), the authority intends to award a contract to an existing provider following Direct Award Process C under the Provider Selection Regime (PSR). The authority is proposing a new contract to replace the existing contract at the end of its term and the proposed contracting arrangements are not changing considerably. The authority is of the view that the existing provider is satisfying the contract to a sufficient standard and will likely satisfy the proposed contract to a sufficient standard. Representations by providers must be made to decision makers by midnight on 30th June 2026 (8 working days from publication) via email to: cddft.sclprocurement@nhs.net No conflicts of interest were identified during the procurement process. No subcontracting is expected.

• UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUSTAwarded supplier22-265-1193 Birmingham, West Midlands, B15 2PR

No document links were published on the notice.